<DOC>
	<DOCNO>NCT00728156</DOCNO>
	<brief_summary>Patients diabetes likely develop furring coronary artery present angina heart attack . Furthermore , event , poor outcome ( high rate death ) survivor likely recur symptom . Using novel `` clot chamber '' investigator show patient diabetes likely develop blood clot . This study look role different blood thin medication patient diabetes . If successful , investigator provide evidence conduct large clinical study look role additional blood thin medication reduce heart attack stroke patient diabetes .</brief_summary>
	<brief_title>Platelet-dependent Thrombosis : Placebo-controlled Trial Antiplatelet Therapy ( Clopidogrel )</brief_title>
	<detailed_description>The objective study compare effect Clopidogrel platelet dependent thrombosis patient T2DM CAD placebo . The Badimon chamber , ex vivo arterial injury model use purpose . This model simulate vivo situation high shear arterial wall damage help quantify thrombus sum endpoint haemostatic abnormality see vitro .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Patients T2DM CAS define : Clinical definition T2DM : Diagnosed accord WHO criteria [ 53 ] . CAD : Presence one following : Angina plus positive exercise tolerance test , enzyme and/or Q wave positive myocardial infarction , angiographic evidence ( &gt; 50 % stenosis one vessel ) , percutaneous surgical coronary revascularisation . Aged 18 75 Provided write consent participation trial prior studyspecific procedure requirement . Contraindication Clopidogrel Smoking ( current smoker patient quit smoke less six month ) Malignancy ( diagnose investigation ) Haematological disorder ( Anaemia , malignancy , bleed disorder ) Women childbearing potential Use corticosteroids/other antithrombotic agent ( warfarin ) Chronic liver disease ( Cirrhosis , malignancy patient twice upper limit liver function test ) Unable consent . Use investigational study drug within 1 year prior study entry Previous participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Type 2 Diabetes mellitus</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>Platelet dependent thrombogenicity</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Badimon Chamber</keyword>
</DOC>